Triple
T19157066
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | MRK |
E468952
|
entity |
| Predicate | issuerAlsoKnownAs |
P134646
|
FINISHED |
| Object | Merck Sharp & Dohme |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Merck Sharp & Dohme | Statement: [MRK, issuerAlsoKnownAs, Merck Sharp & Dohme]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Merck Sharp & Dohme Context triple: [MRK, issuerAlsoKnownAs, Merck Sharp & Dohme]
-
A.
Merck & Co.
chosen
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
-
B.
Merck KGaA
Merck KGaA is a German multinational science and technology company specializing in healthcare, life science, and electronics.
-
C.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
D.
GlaxoSmithKline
GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
-
E.
Smith, Kline & French
Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: issuerAlsoKnownAs Context triple: [MRK, issuerAlsoKnownAs, Merck Sharp & Dohme]
-
A.
issuerAlsoKnownFor
Indicates that the issuer is additionally recognized or notable for another role, activity, or attribute beyond their primary identified capacity.
-
B.
issuerCurrentName
Indicates the current official name by which the issuer is presently identified.
-
C.
issuerFormerParent
Indicates that the subject entity was formerly the parent (e.g., controlling or owning entity) of the issuer entity, but no longer holds that parent status.
-
D.
issuerBestKnownFor
Indicates the primary work, achievement, or characteristic for which an issuer is most widely recognized.
-
E.
issuerNameShort
Indicates the abbreviated or shortened form of the name of the entity acting as the issuer.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8dd084ff48190ac0f8c46ee722629 |
completed | April 10, 2026, 11:20 a.m. |
| NER | Named-entity recognition | batch_69e5eeb9cf9081908b17073755e83554 |
completed | April 20, 2026, 9:15 a.m. |
| PD | Predicate disambiguation | batch_69e4b9b83d6881908e6271c620f74100 |
completed | April 19, 2026, 11:17 a.m. |
| PDg | Predicate description generation | batch_69e4bfe9ef7081908a74a57d1fc731ea |
completed | April 19, 2026, 11:43 a.m. |
Created at: April 10, 2026, 12:06 p.m.